• SPX
  • $5,961.44
  • 0.21 %
  • $12.73
  • DJI
  • $44,202.94
  • 0.76 %
  • $332.58
  • N225
  • $38,283.85
  • 0.68 %
  • $257.68
  • FTSE
  • $8,266.48
  • 1.44 %
  • $117.21
  • IXIC
  • $18,968.48
  • -0.02 %
  • -$3.94
Scopus BioPharma Inc. (SCPS) Stock Price, News & Analysis

Scopus BioPharma Inc. (SCPS) Stock Price, News & Analysis

Currency in USD Disclaimer

$0.00

-$0

(0%)

Day's range
$0
Day's range
$0
50-day range
$9.9999997E-5
Day's range
$0.01
  • Country: US
  • ISIN: US8091711015
52 wk range
$0
Day's range
$0.06
  • CEO: Dr. Alan D. Horsager Ph.D.
  • Website: Visit Site


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score -250.87
  • Piotroski Score 1.00
  • Grade N/A
  • Symbol (SCPS)
  • Company Scopus BioPharma Inc.
  • Price $0.00
  • Changes Percentage (0%)
  • Change -$0
  • Day Low $0.00
  • Day High $0.00
  • Year High $0.06

Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. The company lead development programs are immuno-oncology gene therapy for the treatment of various cancers. It offers Duet Platform, a CpG signal transducer and activator of transcription 3 (STAT3) inhibitors; and MRI-1867, rationally designed, orally available, dual-action, hybrid, and small molecule that is an inverse agonist of the endocannabinoid system/cannabinoid receptor 1, as well as an inhibitor of inducible nitric oxide synthase. Scopus BioPharma Inc. has strategic partnerships with the City of Hope, National Institutes of Health Program, and The Hebrew University of Jerusalem for its lead development and other programs. The company was formerly known as Project18 Inc. and changed its name to Scopus BioPharma Inc. in December 2017. Scopus BioPharma Inc. was incorporated in 2017 and is headquartered in New York, New York.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 05/12/2023
  • Fiscal Year End N/A

  • Average Stock Price Target $0.00
  • High Stock Price Target $0.00
  • Low Stock Price Target $0.00
  • Potential Upside/Downside N/A
  • Consensus Rating Neutral
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$0.31
  • Trailing P/E Ratio 0
  • Forward P/E Ratio 0
  • P/E Growth 0
  • Net Income $-11,609,827

Income Statement

Quarterly

Annual

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Scopus BioPharma Inc. Frequently Asked Questions

  • What were the earnings of SCPS in the last quarter?

    In the last quarter Scopus BioPharma Inc. earnings were on Friday, November, 12th. The Scopus BioPharma Inc. maker reported -$0.08 EPS for the quarter, beating analysts' consensus estimates of -$0.23 by $0.15.

  • What is the Scopus BioPharma Inc. stock price today?

    Today's price of Scopus BioPharma Inc. is $0.00 — it has decreased by 0% in the past 24 hours. Watch Scopus BioPharma Inc. stock price performance more closely on the chart.

  • Does Scopus BioPharma Inc. release reports?

    Yes, you can track Scopus BioPharma Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Scopus BioPharma Inc. stock forecast?

    Watch the Scopus BioPharma Inc. chart and read a more detailed Scopus BioPharma Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is Scopus BioPharma Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by Scopus BioPharma Inc. stock ticker.

  • How to buy Scopus BioPharma Inc. stocks?

    Like other stocks, SCPS shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Scopus BioPharma Inc.'s EBITDA?

    Scopus BioPharma Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Scopus BioPharma Inc.’s financial statements.

  • What is the Scopus BioPharma Inc.'s net income ratio for the financial year 2022?

    The net income ratio for the financial year 2022 is 0, which equates to approximately 0.00%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Scopus BioPharma Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Scopus BioPharma Inc.'s financials relevant news, and technical analysis. Scopus BioPharma Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Scopus BioPharma Inc. stock currently indicates a “sell” signal. For more insights, review Scopus BioPharma Inc.’s technical analysis.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.